ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 483,07
0,37%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Celator Pharmaceuticals Inc. (MM) (CPXX)

  7. Celator Pharmaceuticals Inc. (MM) (CPXX) Actualités

CPXX

Celator Pharmaceuticals Inc. (CPXX)

Celator Pharmaceuticals Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CPXX
DateHeureSourceTitreSymboleSociété
13/02/201821h59Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
15/02/201721h12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
02/08/201622h02Edgar (US Regulatory)Amended Termination of Registration of a Class of Security Under Section 12(b) (15-12b/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
02/08/201612h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
27/07/201623h50Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
22/07/201617h30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
15/07/201622h50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
13/07/201619h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h10Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201615h14Edgar (US Regulatory)(25-NSE)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201614h43Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201614h41Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201607h50PR Newswire (US)Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celat...NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
27/06/201606h10PR Newswire (US)Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. AcquisitionNASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
17/06/201614h00PR Newswire (US)Drugs - Generic Stocks Technical Data - Allergan, Mylan, Horizon Pharma, and Celator PharmaNASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
15/06/201623h06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
14/06/201613h00PR Newswire (US)Celator Pharmaceuticals® Announces Positive Results in Patients with FLT3 Mutation from the Phase 3 Trial in High-Risk Acute...NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
14/06/201601h00Business WireINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourage...NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
10/06/201622h07Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
10/06/201622h03Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
06/06/201613h00PR Newswire (US)Celator Pharmaceuticals® Presented Phase 3 Trial Results in Patients with High-Risk Acute Myeloid Leukemia Demonstrating VYX...NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
04/06/201600h21PR Newswire (US)Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX ShareholdersNASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
02/06/201619h21Business WireCELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to J...NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
02/06/201615h11PR Newswire (US)SHAREHOLDER ALERT: Law Offices of Marc S. Henzel Announces Investigation into the proposed sales and mergers of American Capi...NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
01/06/201617h18Business WireCELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
01/06/201615h26Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
31/05/201623h26Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
31/05/201623h04PR Newswire (US)Harwood Feffer LLP Announces Investigation of Celator Pharmaceuticals, Inc.NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:CPXX

Dernières Valeurs Consultées

TG
1AJ2
Vision Lithium
COIN
BNBBGBP
EU
SAN
Sanofi
COIN
PDXUSD
EU
COR30
Euronext Core Europe EW3...
BITMOT
766953
Belgium Tf 4,5% Mz26 Eur
TG
KUO1
Kubota
EU
INHSI
Lyxor HSI Inav
LSE
74GI
B'ham.cp 3%47
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés